Low Ki-67 labeling index is a clinically useful predictive factor for recurrence-free survival in patients with papillary thyroid carcinoma
We believe the evidence for low tumor recurrence risk may contribute to use of more conservative treatment options for invasive-stage PTCs and help alleviate patient anxiety about tumor recurrence and death.
Authors
- Ryuji Yasumatsu (ORCID: https://orcid.org/0000-0001-6199-0341)
- Katsunari Yane (ORCID: https://orcid.org/0009-0003-7990-4386)
- Takashi Masui (ORCID: https://orcid.org/0000-0002-9567-2947)
- Ichiro Ota (ORCID: https://orcid.org/0000-0003-3815-8877)
- Tadashi Kitahara (ORCID: https://orcid.org/0000-0002-5260-6202)
- Kennichi Kakudo (ORCID: https://orcid.org/0000-0002-0347-7264)
- Hirotaka Kinugawa (ORCID: https://orcid.org/0009-0007-0248-7157)
- Tomoko Wakasa (ORCID: https://orcid.org/0000-0002-3328-5677)
- Satoru Koike
Institutions
- Izumi City General Hospital (JP)
- Nara Medical University (JP)
- Kindai University (JP)
Publication Details
- Journal
- Journal of Pathology and Translational Medicine
- Published
- 2025-02-18
- DOI
- https://doi.org/10.4132/jptm.2024.11.08
- Citations
- 3
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.88